In fact, dyslipidemia is often detected in hypertensive patients, and circulating levels of specific lipoproteins, including Lp(a), can contribute to the development of subclinical and overt hypertension-related organ damage [66,67]. The gene discussed is LPA; the disease is hypertensive disorder.